New Hampshire 2025 Regular Session

New Hampshire Senate Bill SB256

Introduced

1/23/25

Refer

1/23/25

Refer

2/21/25

Refer

3/6/25

Caption

Relative to the affordability and safety of clinician administered drugs.

Latest SB256 Activity

Companion Bills

No companion bills found.

Previously Filed As

NH HB513

Relative to affordability and safety of clinician administered drugs.

NH HB513

Relative to affordability and safety of clinician administered drugs.

NH HB1601

Relative to the prescription drug affordability board.

NH SB354

Relative to insurance cost-sharing calculations.

NH HB1571

Relative to requiring insurance coverage for glucose monitoring devices for people with diabetes.

NH SB561

Relative to prior authorizations for health care.

NH SB555

Relative to receipt of pharmaceutical rebates by insurers and pharmacy benefits managers.

NH SB495

Relative to certification of alcohol and other drug use treatment facilities.

NH HB1283

Relative to end of life options.

NH HB1604

Relative to the use of electronic medical records.

Similar Bills

RI H5680

Accident And Sickness Insurance Policies

RI S0870

Accident And Sickness Insurance Policies

RI H7365

Provides that health insurers provide coverage for covered clinician-administered drugs under certain circumstances.

RI S2086

Prohibits healthcare entities from interfering with a patient's right to choose to obtain a clinician-administered drug from their provider or pharmacy of choice.

RI H8254

Accident And Sickness Insurance Policies

MA H1313

Relating to patient choice in dispensing of clinician-administered drugs

WV HB3067

Protecting patient access to clinician-administered medications.

CA SB1452

Biological products.